ITC Has Few Answers On How IP Constrains COVID Treatments
Economists at the U.S. International Trade Commission have handed down their doorstop-worthy take on how available COVID-19 treatments are around the world. Though it didn't take sides, the report touched on...To view the full article, register now.
Already a subscriber? Click here to view full article